Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 9151-9200 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT06209281
A Phase III Clinical Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops
PHASE3
Active, not recruiting
526 participants
Started: May 13, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05338307
Preliminary Investigation of β-hydroxybutyrate Supplementation in Colorectal Cancer Prevention
NA
Active, not recruiting
20 participants
Started: May 13, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05369299
Clinical Outcome of Two-piece Zirconia Implants in Immediate Implant Placement
NA
Active, not recruiting
33 participants
Started: May 13, 2022 · Completed: Nov 1, 2025
1 condition
1 sponsor
1 location
NCT05368259
The AUDACITY Study (AllUrion Device in Adults With Clinical ObesITY)
NA
Active, not recruiting
1,000 participants
Started: May 12, 2022 · Completed: Mar 1, 2025
1 condition
1 sponsor
17 locations
NCT05267535
Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease
PHASE2/PHASE3
Active, not recruiting
225 participants
Started: May 12, 2022 · Completed: Jun 30, 2025
1 condition
2 sponsors
37 locations
NCT05119036
Adjuvant Treatment Deintensification After Transoral Surgery for Human Papillomavirus-Positive Squamous Cell Carcinoma
NA
Active, not recruiting
83 participants
Started: May 12, 2022 · Completed: Apr 30, 2026
2 conditions
1 sponsor
2 locations
NCT05285904
Kesimpta® (Ofatumumab) in Swiss Multiple Sclerosis Patients - an Observational Study
N/A
Active, not recruiting
107 participants
Started: May 12, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
13 locations
NCT05357482
Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia
PHASE1/PHASE2
Active, not recruiting
40 participants
Started: May 12, 2022 · Completed: Jan 31, 2027
2 conditions
1 sponsor
1 location
NCT05304468
Reduced-dose Versus Standard Dose Radiotherapy for Nasopharyngeal Carcinomain
PHASE3
Active, not recruiting
452 participants
Started: May 11, 2022 · Completed: Oct 29, 2029
1 condition
1 sponsor
1 location
NCT04339452
Impella Supported OPCABG
N/A
Active, not recruiting
30 participants
Started: May 11, 2022 · Completed: Mar 31, 2026
1 condition
2 sponsors
1 location
NCT05307705
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
PHASE1
Active, not recruiting
193 participants
Started: May 11, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
50 locations
NCT05311618
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
PHASE1
Active, not recruiting
71 participants
Started: May 11, 2022 · Completed: Jun 30, 2025
16 conditions
2 sponsors
6 locations
NCT05441943
Lymphaticovenous Anastomosis as Treatment for Lymphedema
NA
Active, not recruiting
10 participants
Started: May 11, 2022 · Completed: Dec 31, 2026
22 conditions
2 sponsors
1 location
NCT06376006
Evaluating Learning Curves and Competence in Colorectal Endoscopic Mucosal Resection Among Advanced Endoscopy Trainees
N/A
Active, not recruiting
42 participants
Started: May 11, 2022 · Completed: Dec 1, 2024
2 conditions
20 sponsors
1 location
NCT06589076
Apical Periodontitis and Mental Health
N/A
Active, not recruiting
71 participants
Started: May 11, 2022 · Completed: Sep 30, 2024
3 conditions
1 sponsor
1 location
NCT05382000
Artificial Intelligence (IA) Advanced Triage Tool for G&O Emergencies
NA
Active, not recruiting
450 participants
Started: May 11, 2022 · Completed: Dec 1, 2024
1 condition
1 sponsor
1 location
NCT05209035
Evaluation of Trazodone in OSA-MCI
PHASE4
Active, not recruiting
134 participants
Started: May 10, 2022 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT05344469
A NIS Evaluating Injectable Treatments in Patients With Relapsing Multiple Sclerosis
N/A
Active, not recruiting
564 participants
Started: May 10, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
90 locations
NCT05064150
Neuroendocrine Tumors - Patient Reported Outcomes
N/A
Active, not recruiting
2,539 participants
Started: May 10, 2022 · Completed: Jun 30, 2026
4 conditions
19 sponsors
14 locations
NCT03399773
Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes
PHASE2
Active, not recruiting
31 participants
Started: May 10, 2022 · Completed: Apr 2, 2027
6 conditions
4 sponsors
1 location
NCT04939597
A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor
PHASE3
Active, not recruiting
192 participants
Started: May 10, 2022 · Completed: Sep 30, 2027
1 condition
1 sponsor
138 locations
NCT05574920
Characterizing Breast Cancer With Al18F-NOTA-FAPI-04 PET/CT (PFB-02)
NA
Active, not recruiting
88 participants
Started: May 10, 2022 · Completed: Feb 1, 2024
1 condition
1 sponsor
1 location
NCT06727942
Virtual Reality-Infused Treadmill Training on Aging-Related Outcomes
NA
Active, not recruiting
60 participants
Started: May 10, 2022 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT05202860
Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients with Actinic Keratosis
PHASE2
Active, not recruiting
70 participants
Started: May 9, 2022 · Completed: Jun 19, 2034
3 conditions
1 sponsor
1 location
NCT05069558
Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion
NA
Active, not recruiting
450 participants
Started: May 9, 2022 · Completed: Oct 26, 2026
3 conditions
1 sponsor
48 locations
NCT05160701
Bringing Health Home
NA
Active, not recruiting
300 participants
Started: May 9, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05279846
A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)
PHASE3
Active, not recruiting
350 participants
Started: May 9, 2022 · Completed: Jan 31, 2025
1 condition
1 sponsor
35 locations
NCT04272073
A High-PRotein Mediterranean Diet and Resistance Exercise for Cardiac Rehabilitation
NA
Active, not recruiting
240 participants
Started: May 9, 2022 · Completed: Feb 29, 2024
2 conditions
2 sponsors
1 location
NCT05309265
Vocational Rehabilitation for the Return to Work of Breast Cancer Patients: a Feasibility Study
NA
Active, not recruiting
16 participants
Started: May 9, 2022 · Completed: Nov 30, 2025
2 conditions
1 sponsor
1 location
NCT05362591
Anterior Resin Bonded Restorations for Adolescent
NA
Active, not recruiting
24 participants
Started: May 8, 2022 · Completed: Jun 1, 2024
1 condition
1 sponsor
1 location
NCT05432648
Fiber Food Introduction in Pediatric Short Bowel Syndrome
NA
Active, not recruiting
60 participants
Started: May 8, 2022 · Completed: May 31, 2026
1 condition
2 sponsors
1 location
NCT05306457
CNS10-NPC-GDNF Delivered to the Motor Cortex for ALS
PHASE1
Active, not recruiting
16 participants
Started: May 8, 2022 · Completed: Oct 31, 2026
1 condition
2 sponsors
1 location
NCT05314023
Immunogenicity and Safety of V503 in Chinese Males 9 Through 19 Years Old (V503-053)
PHASE3
Active, not recruiting
1,590 participants
Started: May 7, 2022 · Completed: Feb 19, 2029
1 condition
1 sponsor
5 locations
NCT05155059
Non-invasive Intermittent Theta Burst Stimulation of the Dorsolateral Prefrontal Cortex in Functional Movement Disorders
PHASE2
Active, not recruiting
21 participants
Started: May 6, 2022 · Completed: Dec 1, 2026
1 condition
1 sponsor
1 location
NCT05285813
A Phase II Study of Vibecotamab (XmAb14045) for MRD- Positive AML and MDS After Hypomethylating Agent Failure
PHASE2
Active, not recruiting
42 participants
Started: May 6, 2022 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05310773
Couples Health CoOp Plus
NA
Active, not recruiting
962 participants
Started: May 6, 2022 · Completed: Nov 30, 2025
3 conditions
2 sponsors
1 location
NCT05516940
A Study of the Impact of Different Delivery Modes on Specific Macronutrient Components in Human Milk
N/A
Active, not recruiting
250 participants
Started: May 6, 2022 · Completed: Jun 30, 2024
1 condition
4 sponsors
1 location
NCT04818073
Determinants of the Effectiveness of Robot-assisted Hand Movement Training
NA
Active, not recruiting
60 participants
Started: May 6, 2022 · Completed: Aug 31, 2025
2 conditions
3 sponsors
1 location
NCT07204366
Autoantibodies Against Type I Interferon in Patients Affected With Ph-negative Myeloproliferative Neoplasms (MPN-IFN Study)
N/A
Active, not recruiting
219 participants
Started: May 6, 2022 · Completed: Dec 31, 2030
2 conditions
1 sponsor
1 location
NCT05436327
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
NA
Active, not recruiting
479 participants
Started: May 6, 2022 · Completed: Jan 31, 2027
3 conditions
2 sponsors
1 location
NCT05408884
Miracle Messages Evaluation
NA
Active, not recruiting
759 participants
Started: May 6, 2022 · Completed: Dec 15, 2024
1 condition
2 sponsors
1 location
NCT05258305
AuraClens™ System in Processing of Lipoaspirate for Autologous Fat Grafting to the Breast
NA
Active, not recruiting
200 participants
Started: May 5, 2022 · Completed: Nov 30, 2024
1 condition
1 sponsor
15 locations
NCT04289376
Quiet Eye Duration in Baseball
NA
Active, not recruiting
21 participants
Started: May 5, 2022 · Completed: Jul 31, 2025
1 condition
1 sponsor
1 location
NCT04833790
What Drives Poor Care for Child Diarrhea: A Standardized Patient Experiment
NA
Active, not recruiting
2,451 participants
Started: May 5, 2022 · Completed: Jun 1, 2025
1 condition
1 sponsor
1 location
NCT05337137
A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer
PHASE1/PHASE2
Active, not recruiting
162 participants
Started: May 5, 2022 · Completed: Nov 7, 2025
1 condition
1 sponsor
61 locations
NCT05354323
NECVAX-NEO1 in Addition to Checkpoint Inhibitor in Patients With Solid Tumors
PHASE1
Active, not recruiting
6 participants
Started: May 5, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
3 locations
NCT05775029
RSI Observation Follow-up
N/A
Active, not recruiting
2,300 participants
Started: May 5, 2022 · Completed: Jun 1, 2025
4 conditions
1 sponsor
2 locations
NCT06724471
Preservation of Women's Fertility: Evaluation of Innovative Methods for Ovarian Tissue Cryopreservation
N/A
Active, not recruiting
30 participants
Started: May 5, 2022 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT05369845
Observance of Continuous Positive Pressure for the Treatment of Obstructive Sleep Apnea Syndrome
NA
Active, not recruiting
132 participants
Started: May 5, 2022 · Completed: Jun 30, 2026
4 conditions
1 sponsor
1 location
NCT05171049
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
PHASE3
Active, not recruiting
1,150 participants
Started: May 5, 2022 · Completed: Feb 28, 2027
3 conditions
2 sponsors
209 locations
Previous
1
More pages
181
182
183
184
185
186
187
More pages
431
Next